BIRC5 and hepatocellular carcinoma: The success of survivin-targeted RNAi treatment depends mainly on the efficient delivery of specific siRNA to HCC cells, since siRNAs can be rapidly degraded by extracellular RNase and cleared by renal filtration [5].